You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ESCC

Showing 226 - 250 of 250
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumors Trial in Darmstadt (Sym004)

Completed
Has Results
  • Solid Tumors
  • Darmstadt, Germany
    Please contact the Merck KGaA Communication Center located in
Jul 19, 2017

Esophageal Cancer, Chemoradiation, Surgery Trial in Shanghai (radiotherapy, Surgery)

Unknown status
  • Esophageal Cancer
  • +2 more
  • radiotherapy
  • Surgery
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Oct 18, 2016

Metastatic Esophageal Squamous Carcinoma, Gastric Cancer Trial in Beijing (Palliative care)

Unknown status
  • Metastatic Esophageal Squamous Carcinoma
  • Gastric Cancer
  • Palliative care
  • Beijing, Beijing, China
    Peking Universtiy Cancer Hospital
Feb 24, 2015

Esophageal Tumors Trial in Shanghai (drug, radiation, other)

Unknown status
  • Esophageal Neoplasms
  • Adjuvant chemotherapy (Paclitaxel and Cisplatin)
  • +2 more
  • Shanghai, China
    Shanghai Chest Hospital
Sep 6, 2016

Gastric Dysplasia, Neoplasia Trial in Porto (Radiofrequency ablation of dysplastic mucosa (HALO))

Completed
  • Gastric Dysplasia
  • Neoplasia
  • Radiofrequency ablation of dysplastic mucosa (HALO)
  • Porto, Portugal
    Gastroenterology Department, Hospital de Sao Joao
Feb 18, 2016

Prosthesis Survival Trial in China (drug, radiation, other)

Unknown status
  • Prosthesis Survival
  • Beijing, Beijing, China
  • +13 more
Apr 19, 2016

Esophageal Squamous Cell Carcinoma Trial (Cytokine-induced Killer Cells)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Cytokine-induced Killer Cells
  • (no location specified)
Jul 2, 2015

Esophageal Squamous Dysplasia Prevalence at Tenwek Hospital

Completed
  • Esophageal Dysplasia
    • Bomet, Riftvalley, Kenya
      Tenwek Hospital
    Feb 26, 2015

    Esophageal Cancer Trial in Guangzhou (Extraesophageal saline injection (ESI))

    Unknown status
    • Esophageal Cancer
    • Extraesophageal saline injection (ESI)
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Aug 22, 2013

    Esophageal Squamous Cell Carcinoma Trial in Handan (Endoscopy examination with iodine staining)

    Completed
    • Esophageal Squamous Cell Carcinoma
    • Endoscopy examination with iodine staining
    • Handan, Hebei, China
      Cancer Institute/Hospital of Ci County
    Mar 20, 2014

    Esophageal Squamous Cell Carcinoma Trial in Hangzhou (albumin-bound paclitaxel plus cisplatin)

    Completed
    • Esophageal Squamous Cell Carcinoma
    • albumin-bound paclitaxel plus cisplatin
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Jul 28, 2014

    Squamous Cell Esophageal Carcinoma Trial in Linhai (procedure, drug, device)

    Unknown status
    • Squamous Cell Esophageal Carcinoma
    • Neo-adjuvant Chemoradiotherapy followed by Mckeown MIE
    • +2 more
    • Linhai, Zhejiang, China
      Thaizhou Hospital
    Jul 9, 2014

    Squamous Cell Carcinoma Trial in Zurich (Lapatinib)

    Terminated
    • Squamous Cell Carcinoma
    • Zurich, ZH, Switzerland
      University Hospital Zurich, Division of Dermatology
    Dec 2, 2014

    Pelvic Pain, Depression Trial in Rochester (Interpersonal Therapy for Pain (IPT-P), Enhanced Support and Connection to

    Completed
    • Pelvic Pain
    • Depression
    • Interpersonal Therapy for Pain (IPT-P)
    • Enhanced Support and Connection to Counseling
    • Rochester, New York
      University of Rochester Medical Center
    Mar 12, 2014

    Esophageal Squamous Cell Cancer Trial in Beijing (nimotuzumab)

    Unknown status
    • Esophageal Squamous Cell Cancer
    • Beijing, Beijing, China
      Peking University Cancer Hospital
    Nov 20, 2013

    Esophageal Squamous Cell Cancer Trial in Beijing (Sequential chemo (paclitaxel 175mg/m2 d1; cisplatin 37.5mg/m2 d1,d2) and

    Unknown status
    • Esophageal Squamous Cell Cancer
    • Sequential chemotherapy (paclitaxel 175mg/m2 d1; cisplatin 37.5mg/m2 d1,d2) and radiotherapy
    • Beijing, Beijing, China
      Peking University Cancer Hospital
    Dec 13, 2013

    Esophageal Squamous Cell Cancer, Elderly Patients Trial in Beijing (Sequential chemo (paclitaxel 80mg/m2 d1,d8) and

    Unknown status
    • Esophageal Squamous Cell Cancer
    • Elderly Patients
    • Sequential chemotherapy （paclitaxel 80mg/m2 d1,d8) and radiotherapy
    • Beijing, Beijing, China
      Peking University Cancer Hospital
    Dec 13, 2013

    Esophageal Squamous Carcinoma Trial in Beijing (Paclitaxel, Erlotinib, Radiation therapy)

    Unknown status
    • Esophageal Squamous Carcinoma
    • Beijing, Beijing, China
      307 Hospital of PLA
    Dec 16, 2012

    Carcinoma, Squamous Cell Trial in Beijing (Aspirin, Tea Polyphenols)

    Unknown status
    • Carcinoma, Squamous Cell
    • Beijing, China
      Beijing Friendship Hospital Capital Medical University
    Dec 17, 2011

    VEGF-C and miRNA and Clinical Non-small Cell Lung Cancer and

    Unknown status
    • VEGFC Protein in Serum
    • +4 more
      • (no location specified)
      Nov 12, 2010

      Esophageal Cancer Trial in Wakayama (DCF)

      Unknown status
      • Esophageal Cancer
      • Wakayama, Japan
        Wakayama Medical University
      Sep 8, 2010

      Esophageal Cancer Trial in Chuo (vaccination)

      Unknown status
      • Esophageal Cancer
      • vaccination
      • Chuo, Yamanashi, Japan
        University of Yamanashi, First Department of Surgery
      Dec 27, 2010

      Esophageal Cancer Trial in Taipei (Cetuximab, Paclitaxel, Cisplatin)

      Unknown status
      • Esophageal Cancer
      • Taipei, Taiwan
        National Taiwan University Hospital
      Dec 16, 2009

      Esophageal Cancer Trial in Chuo (peptide)

      Unknown status
      • Esophageal Cancer
      • peptide
      • Chuo, Yamanashi, Japan
        First Department of Surgery, University of Yamanashi
      Oct 14, 2009

      Esophageal Cancer Trial in 1110 Shimokato, Chuo-city (TTK, LY6K, and IMP-3 peptides)

      Unknown status
      • Esophageal Cancer
      • TTK, LY6K, and IMP-3 peptides
      • 1110 Shimokato, Chuo-city, Yamanashi, Japan
        University of Yamanashi, First Department of Surgery
      May 23, 2008